US Patent 11091521 Immunogenic compositions comprising

Patent 11091521 was granted and assigned to Infectious Disease Research Institute on August, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Infectious Disease Research Institute

Current Assignee

Infectious Disease Research Institute

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

110915210

Patent Inventor Names

Sylvie Bertholet0

Rhea N. Coler0

Steven G. Reed0

Gregory C. Ireton0

Date of Patent

August 17, 2021

Patent Application Number

201711160

Date Filed

November 16, 2017

Patent abstract

The present invention relates to compositions and fusion proteins containing at least two Mycobacterium sp. antigens, and polynucleotides encoding such compositions and fusion proteins. The invention also relates to methods for their use in the treatment, prevention and/or diagnosis of tuberculosis infections.